TRUCODE GENE REPAIR, INC.
Biotech · Private
Fluorescent gammaPNA miniprobes for telomere and mRNA analysis
- Grants
- $578K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 9
- 0 granted · 9 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · GammaPNA Miniprobes for Telomere Analysis and RNA FISH | $175,509 | |
| Federal grant | Department of Health and Human Services · Phase II · GammaPNA Miniprobes for Telomere Analysis and RNA FISH | $402,856 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2911 | Percev LLC | — | — |
| 2912 | Aiolos Bio | — | — |
| 2913 | GENSAIC, INC. | — | — |
| 2914 | TRUCODE GENE REPAIR, INC. | — | — |
| 2915 | Sermonix Pharmaceuticals, Inc. | — | $43M |
| 2916 | VACCINEX, INC. | — | $44M |
| 2917 | STELLATE DNA LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Peptide Nucleic Acid (pna) Monomers With An Orthogonally Protected Ester Moiety And Novel Intermediates And Methods Related Theretoapplication
- Lipid Nanoparticle Formulations Of Nucleic Acid Mimicsapplication
- Polymer-based Nanoparticles, Related Formulation Methods, And Apparatusapplication
- Compositions, Technologies And Methods Of Using Plerixafor To Enhance Gene Editingapplication
- Peptide Nucleic Acid (pna) Monomers With An Orthogonally Protected Ester Moiety And Novel Intermediates And Methods Related Theretoapplication
- Peptide Nucleic Acid (pna) Monomers With An Orthogonally Protected Ester Moietyapplication
- Peptide Nucleic Acid (PNA) Monomers With An Orthogonally Protected Ester Moiety and Novel Intermediates and Methods Related Theretoapplication
- Compositions, Technologies And Methods Of Using Plerixafor To Enhance Gene Editingapplication
- Peptide Nucleic Acid (PNA) Monomers With An Orthogonally Protected Ester Moietyapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.